SynthesisTranslational psychiatry2025
Identification of 1q25.2 as a novel shared locus between schizophrenia and major depressive disorder in east Asians by integrative analyses.
Synthesis in Translational psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quo Vadis translational neuroscience?Translational neuroscience · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Schizophrenia (SZ) and major depressive disorder (MDD) share psychopathological features, and their overlapped genetic architectures have been well-studied in Europeans. However, the extent of their polygenic overlap in East Asians remains unclear. Genome-wide association study (GWAS) datasets present a valuable resource for exploring this question. We applied linkage disequilibrium score (LDSC) regression and MiXeR analyses to assess polygenic overlap. Cross-trait meta-analysis was used to identify shared genomic loci between disorders. Expression quantitative trait loci (eQTL) and diagnostic analyses of mRNA expression were utilized to localize risk gene(s). Using GWAS datasets of SZ (29,519 cases and 44,392 controls) and MDD (7753 cases and 14,046 controls), we conducted LDSC regression and MiXeR analyses, revealing substantial genetic overlap between the two disorders. Genome-wide meta-analysis highlighted a novel risk locus at 1q25.2. The risk SNPs at this locus showed significant eQTL associations with FAM20B mRNA expression across the brain and blood, consistent with higher gene expression observed in cases. We highlighted a novel genome-wide risk locus in East Asians linked to SZ and MDD, reinforcing evidence for their shared genetic overlap. Our study emphasizes the significance of mining public datasets to explore psychiatric risk genes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.